About
Gilead Sciences appears at No. 233 in the 2026 Global 2000, a multi-factor ranking based on sales, profits, assets and market value. The company is headquartered in Foster City, California, United States and operates primarily in drugs & biotechnology. Reported figures used for the ranking include $29.8B in sales, $9.2B in profit, $56.3B in assets and a market value of $160.9B.